Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities

Treatment of pediatric-onset multiple sclerosis (POMS) has been tailored after observational studies and data obtained from clinical trials in adult-onset multiple sclerosis (AOMS) patients. There are an increasing number of new therapeutic agents for AOMS, and many will be formally studied for use...

Descripción completa

Detalles Bibliográficos
Autores principales: Margoni, Monica, Rinaldi, Francesca, Perini, Paola, Gallo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165183/
https://www.ncbi.nlm.nih.gov/pubmed/34079516
http://dx.doi.org/10.3389/fneur.2021.676095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165183/
https://www.ncbi.nlm.nih.gov/pubmed/34079516
http://dx.doi.org/10.3389/fneur.2021.676095

Ejemplares similares